Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics
Today's Latest Price: $23.18 USD
Dec 4 4:00pm Add FOLD to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
FOLD Stock Summary FOLD's price/sales ratio is 24.65; that's higher than the P/S ratio of 92.56% of US stocks. With a year-over-year growth in debt of 114.6%, Amicus Therapeutics Inc's debt growth rate surpasses 89.35% of about US stocks. Revenue growth over the past 12 months for Amicus Therapeutics Inc comes in at 53.9%, a number that bests 90.35% of the US stocks we're tracking. Stocks that are quantitatively similar to FOLD, based on their financial statements, market capitalization, and price volatility, are PTCT, FPRX, RMBS, XLRN, and MGEN. Visit FOLD's SEC page to see the company's official filings. To visit the company's web site, go to www.amicusrx.com.
FOLD Price/Volume Stats
Amicus Therapeutics, Inc. (FOLD) Company Bio
Amicus Therapeutics is developing treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.
FOLD Latest News Stream
All News Types
Acquisition Commentary Corp. News Cramer Debt Offering Downgrade Earnings Guidance Up Hedge Fund New Coverage (Bullish) New Coverage (Neutral) Options Product News PT Lowered PT Raised PT Set (Bullish) Rating Reiterated (Bullish) Rating Reiterated (Neutral) Resumes Coverage (Neutral) Stock Offering Upgrade
Loading, please wait...
Latest FOLD News From Around the Web
Below are the latest news stories about Amicus Therapeutics Inc that investors may wish to consider to help them evaluate FOLD as an investment opportunity.
The following slide deck was published by Amicus Therapeutics, Inc. in conjunction with this event....
Amicus Therapeutics (FOLD): Q2 GAAP EPS of -$0.20 beats by $0.07.Revenue of $62.35M (+41.3% Y/Y) beats by $0.08M.Press Release...
Shares of Amicus Therapeutics (NASDAQ:FOLD) rose 0.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share …
FOLD earnings call for the period ending June 30, 2020.
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.
Read More 'FOLD' Stories Here
FOLD Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.8474 seconds.